DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (19)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epirubicin side effects in 58 year old female

Reported by a physician from Taiwan, Province of China on 2012-07-24

Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)

Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Start date: 2010-12-28
    End date: 2010-12-28

Taxotere
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Taxotere
    Start date: 2010-12-28
    End date: 2010-12-28

Epirubicin
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Other drugs received by patient: Granocyte



Possible Epirubicin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23

Patient: 48 year old female

Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06

Epirubicin
    Dosage: 166mg every cycle; 140mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-06

Fluorouracil
    Dosage: 830 mg every cycle; 700 mg, every cycle
    Indication: Breast Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-27

Cyclophosphamide
    Dosage: 830mg, every cycle; 800mg, every cycle
    Indication: non-Small Cell Lung Cancer
    Start date: 2010-10-06
    End date: 2010-10-06



Possible Epirubicin side effects in 46 year old female

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-20

Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Neutropenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18

Ifosfamide
    Start date: 2012-05-17
    End date: 2012-05-18

Mesna
    Start date: 2012-05-17
    End date: 2012-05-18

Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18

Epirubicin
    Start date: 2012-05-17
    End date: 2012-05-18



Possible Epirubicin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20

Patient: 63 year old female

Reactions: Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Cyclophosphamide
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30

Fluorouracil
    Dosage: (df; every cycle), (df; dose reduced)
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-06-30



Possible Epirubicin side effects in 71 year old female

Reported by a consumer/non-health professional from Japan on 2012-06-26

Patient: 71 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Acute Monocytic Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Fluorouracil
    Dosage: twice every 3 weeks x 4 courses
    Indication: Breast Cancer
    Start date: 2010-09-22
    End date: 2010-11-25

Cyclophosphamide
    Dosage: twice every 3 weeks x 4 courses
    Indication: Breast Cancer
    Start date: 2010-09-22
    End date: 2010-11-25

Paclitaxel
    Dosage: weekly x 12 courses
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-09-15

Paraplatin
    Dosage: auc 5 every 3 weeks x 4 courses
    Indication: Breast Cancer
    Start date: 2010-06-30
    End date: 2010-09-15

Epirubicin
    Dosage: twice every 3 weeks x 4 courses
    Indication: Breast Cancer
    Start date: 2010-09-22
    End date: 2010-11-25



Possible Epirubicin side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15

Patient: male

Reactions: Metastases To Adrenals, Neuroblastoma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Start date: 2007-01-01
    End date: 2007-01-01

Cyclophosphamide
    Start date: 2007-01-01
    End date: 2007-01-01

Fluorouracil
    Start date: 2007-01-01
    End date: 2007-01-01



Possible Epirubicin side effects in female

Reported by a individual with unspecified qualification from Germany on 2012-06-07

Patient: female

Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-04-16
    End date: 2012-04-16

Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30

Patient: 49 year old female

Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Dosage: 100 mg
    Administration route: Oral
    Indication: Anaemia

Prednisolone
    Indication: Leukocytosis

Fluorouracil
    Indication: Breast Cancer

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Leukocytosis
    Start date: 2009-07-01

Epirubicin
    Indication: Breast Cancer

Prednisolone
    Dosage: 15 mg
    Indication: Anaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia



Possible Epirubicin side effects in female

Reported by a physician from France on 2012-05-14

Patient: female

Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2008-01-01

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-09-19

Cyclophosphamide
    Start date: 2011-06-01
    End date: 2011-08-01

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-06-01
    End date: 2011-08-01

Epirubicin
    Indication: Breast Cancer

Other drugs received by patient: Carvedilol; Dobutamine HCL



Possible Epirubicin side effects in male

Reported by a physician from Poland on 2012-04-16

Patient: male, weighing 102.0 kg (224.4 pounds)

Reactions: Tumour Lysis Syndrome, Renal Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epirubicin
    Dosage: 100
    Indication: Gastric Cancer
    Start date: 2012-01-26

Capecitabine
    Dosage: 1361
    Indication: Gastric Cancer

Cisplatin
    Dosage: 120
    Indication: Gastric Cancer

Other drugs received by patient: Dexaven (Dexamethasone Sodium Phosphate); Setronon; Mannitol



Possible Epirubicin side effects in 66 year old female

Reported by a individual with unspecified qualification from Japan on 2012-04-10

Patient: 66 year old female

Reactions: Acute Myeloid Leukaemia, Pancytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Capecitabine
    Start date: 2007-06-01
    End date: 2007-09-01

Epirubicin
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-08-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Toremifene
    Start date: 2007-10-01
    End date: 2008-03-01

Anastrozole
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2008-10-01

Taxotere
    Start date: 2006-11-09
    End date: 2007-01-11

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-08-01
    End date: 2007-02-01

Letrozole
    Indication: Breast Cancer
    Start date: 2007-02-01

Capecitabine
    Indication: Breast Cancer
    Start date: 2007-03-01
    End date: 2007-05-01

Toremifene
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2007-09-01

TS-1
    Indication: Breast Cancer Metastatic
    Start date: 2008-10-01
    End date: 2011-06-01

Cyclophosphamide
    Start date: 2007-03-01
    End date: 2007-05-01



Possible Epirubicin side effects in 50 year old female

Reported by a physician from Mexico on 2012-03-30

Patient: 50 year old female, weighing 65.5 kg (144.1 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Cyclophosphamide
    Dosage: 3 cycles.

Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Fluorouracil
    Dosage: 3 cycles.

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Epirubicin
    Dosage: 3 cycles.



Possible Epirubicin side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-21

Patient: 56 year old female

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Fluorouracil
    Indication: Breast Cancer
    Start date: 2003-12-01
    End date: 2004-04-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2003-12-01
    End date: 2004-04-01

Epirubicin
    Indication: Breast Cancer
    Start date: 2003-12-01
    End date: 2004-04-01



Possible Epirubicin side effects in male

Reported by a physician from Poland on 2012-03-19

Patient: male, weighing 102.0 kg (224.4 pounds)

Reactions: Tumour Lysis Syndrome, Renal Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cisplatin
    Dosage: 120
    Indication: Gastric Cancer

Capecitabine
    Dosage: 1361
    Indication: Gastric Cancer

Epirubicin
    Dosage: 100
    Indication: Gastric Cancer
    Start date: 2012-01-26

Other drugs received by patient: Mannitol; Dexaven (Dexamethasone Sodium Phosphate); Setronon



Possible Epirubicin side effects in female

Reported by a physician from France on 2012-02-27

Patient: female

Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-09-19

Epirubicin
    Indication: Breast Cancer

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-06-01
    End date: 2011-08-01

Other drugs received by patient: Cyclophosphamide; Dobutamine HCL; Carvedilol



Possible Epirubicin side effects in female

Reported by a physician from France on 2012-01-27

Patient: female

Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-09-06
    End date: 2011-09-19

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-06-01
    End date: 2011-08-01

Other drugs received by patient: Cyclophosphamide; Carvedilol; Dobutamine HCL



Possible Epirubicin side effects in 66 year old female

Reported by a physician from Japan on 2012-01-04

Patient: 66 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epirubicin
    Dosage: dosage is uncertain.
    Indication: Breast Cancer Metastatic
    Start date: 2006-08-11

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2007-03-01
    End date: 2007-05-01

Cyclophosphamide
    Dosage: dosage is uncertain.
    Start date: 2007-03-01
    End date: 2007-05-01

Xeloda
    Dosage: dosage is uncertain.
    Administration route: Oral
    Start date: 2007-06-01
    End date: 2007-09-01

Cyclophosphamide
    Dosage: dosage is uncertain.
    Indication: Breast Cancer Metastatic
    Start date: 2006-08-11

Other drugs received by patient: Docetaxel (AS Comparator); Toremifene; Fluorouracil; Femara; Toremifene; Calcium Lactate; Urso 250



Possible Epirubicin side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19

Patient: 35 year old female

Reactions: Drug Hypersensitivity, Maternal Exposure Before Pregnancy, Pregnancy, Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Fluorouracil
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Paclitaxel
    Dosage: x1
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer



Possible Epirubicin side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-06

Patient: 42 year old female, weighing 86.0 kg (189.2 pounds)

Reactions: Intracranial Venous Sinus Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aranesp
    Indication: Breast Cancer
    Start date: 2007-06-14
    End date: 2007-08-24

Granisetron
    Dosage: on day 0 to 3
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2007-06-13
    End date: 2007-09-30

Taxol
    Dosage: 40 mg/m2 (09-aug-2007 to 27-sep-2007), weekly.
    Indication: Breast Cancer
    Start date: 2007-08-09
    End date: 2007-10-10

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-06-14
    End date: 2007-07-26

Dexamethasone
    Dosage: daily on day 1 to 4, 4mg (13-jun-2007 to 30-sep-2007).
    Indication: Prophylaxis

Ranitidine
    Dosage: 1 df= 50 units nos, once a day on day 1
    Indication: Antiallergic Therapy

Epirubicin
    Indication: Breast Cancer
    Start date: 2007-06-14
    End date: 2007-07-26

Capecitabine
    Dosage: 500 mg/m2 (09-aug-2007 to 27-sep-2007), twice daily.
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-08-09
    End date: 2007-10-10

Other drugs received by patient: Ibuprofen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014